Michael Secora

Insider Reports History

Location
Salt Lake City, UT
Signature
/s/Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Secora:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Class A Common Stock 1,487,694 $9,186,510 $6.18 15 Nov 2024 Direct
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 348,380 15 Nov 2024 Direct

Insider Reports Filed by Michael Secora

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2024 1 -$73,711 4 Chief Financial Officer 19 Nov 2024, 18:26
RXRX RECURSION PHARMACEUTICALS, INC. 12 Nov 2024 6 -$54,680 4 Chief Financial Officer 14 Nov 2024, 19:19
RXRX RECURSION PHARMACEUTICALS, INC. 08 Oct 2024 6 -$15,306 4 Chief Financial Officer 10 Oct 2024, 18:40
RXRX RECURSION PHARMACEUTICALS, INC. 10 Sep 2024 6 -$12,404 4 Chief Financial Officer 12 Sep 2024, 18:28
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2024 1 -$80,026 4 Chief Financial Officer 19 Aug 2024, 19:09
RXRX RECURSION PHARMACEUTICALS, INC. 13 Aug 2024 6 -$15,609 4 Chief Financial Officer 15 Aug 2024, 17:24
RXRX RECURSION PHARMACEUTICALS, INC. 09 Jul 2024 6 -$43,528 4 Chief Financial Officer 11 Jul 2024, 16:51
RXRX RECURSION PHARMACEUTICALS, INC. 13 Jun 2024 6 -$104,055 4 Chief Financial Officer 17 Jun 2024, 17:46
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2024 1 -$119,740 4 Chief Financial Officer 17 May 2024, 19:11
RXRX RECURSION PHARMACEUTICALS, INC. 16 Apr 2024 6 -$200,507 4 Chief Financial Officer 18 Apr 2024, 17:12
RXRX RECURSION PHARMACEUTICALS, INC. 12 Mar 2024 6 -$370,690 4 Chief Financial Officer 14 Mar 2024, 19:28
RXRX RECURSION PHARMACEUTICALS, INC. 15 Feb 2024 1 -$89,148 4 Chief Financial Officer 16 Feb 2024, 19:59
RXRX RECURSION PHARMACEUTICALS, INC. 13 Feb 2024 7 -$341,485 4 Chief Financial Officer 15 Feb 2024, 18:00
RXRX RECURSION PHARMACEUTICALS, INC. 09 Feb 2024 4 -$25,346 4 Chief Financial Officer 13 Feb 2024, 19:01
RXRX RECURSION PHARMACEUTICALS, INC. 16 Jan 2024 6 -$351,008 4 Chief Financial Officer 18 Jan 2024, 18:37
RXRX RECURSION PHARMACEUTICALS, INC. 12 Dec 2023 6 -$208,138 4 Chief Financial Officer 14 Dec 2023, 18:53
RXRX RECURSION PHARMACEUTICALS, INC. 14 Nov 2023 8 -$225,924 4 Chief Financial Officer 16 Nov 2023, 18:54
RXRX RECURSION PHARMACEUTICALS, INC. 10 Oct 2023 6 -$181,575 4 Chief Financial Officer 12 Oct 2023, 18:07
RXRX RECURSION PHARMACEUTICALS, INC. 12 Sep 2023 6 -$261,450 4 Chief Financial Officer 14 Sep 2023, 19:26
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2023 7 -$331,251 4 Chief Financial Officer 17 Aug 2023, 19:35
RXRX RECURSION PHARMACEUTICALS, INC. 18 Jul 2023 9 -$562,650 4 Chief Financial Officer 19 Jul 2023, 19:07
RXRX RECURSION PHARMACEUTICALS, INC. 13 Jun 2023 6 -$333,645 4 Chief Financial Officer 15 Jun 2023, 19:28
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2023 1 -$26,656 4 Chief Financial Officer 17 May 2023, 18:17
RXRX RECURSION PHARMACEUTICALS, INC. 15 Feb 2023 1 -$10,618 4 Chief Financial Officer 17 Feb 2023, 16:15
RXRX RECURSION PHARMACEUTICALS, INC. 01 Feb 2023 4 -$22,820 4 Chief Financial Officer 03 Feb 2023, 16:14
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2022 1 -$12,631 4 Chief Financial Officer 17 Nov 2022, 17:45
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2022 1 -$13,802 4 Chief Financial Officer 17 Aug 2022, 18:33
RXRX RECURSION PHARMACEUTICALS, INC. 16 May 2022 1 -$6,061 4 Chief Financial Officer 18 May 2022, 19:17
RXRX RECURSION PHARMACEUTICALS, INC. 04 Feb 2022 3 -$7,729 4/A Chief Financial Officer 28 Apr 2023, 16:30